CHELsea is a palliative care, cluster randomised, feasibility trial on clinically-assisted hydration at the end of life in patients with cancer.
The trial objectives include methodological and ethical issues to be understood and addressed to ensure a future robust, adequately powered, randomised controlled trial is designed to understand the impact of clinically-assisted hydration on survival, anti-psychotic drug use and delerium. The protocol for the CHELsea trial has been published (Trials 2015 16:464) and the full publication can be found at http://www.trialsjournal.com/content/16/1/464 or http://ctu.surrey.ac.uk/ctu-publications
Publication: A cluster randomised feasibility trial of clinically assisted hydration in cancer patients in the last days of life, Andrew N Davies1, 2, Melanie Waghorn3, Katherine Webber1, 2, Sigurd Johnsen2, Jeewaka Mendis2, Julia Boyle2, (1Royal Surrey County Hospital, Guildford, UK, 2University of Surrey, Guildford, UK, 3St. Catherine’s Hospice, Crawley, UK), Palliative Medicine 1–11
Article first published online: January 18, 2018 , http://journals.sagepub.com/doi/full/10.1177/0269216317741572
University of Surrey press release: https://www.surrey.ac.uk/mediacentre/press/2018/cancer-patients-given-fl...